CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-14 | Levine Mitchell S Chief Financial Officer | Option exercise | +20,000 | 33,495 | ||
| 2020-03-14 | Levine Mitchell S Chief Financial Officer | Shares withheld for taxes | −6,916 | 26,579 | ||
| 2020-03-14 | Levine Mitchell S Chief Financial Officer | Option exercise · Restricted Stock Units | −20,000 | 0 | ||
| 2020-02-10 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to purchase common stock | +204,000 | 204,000 | ||
| 2020-02-10 | KALAJIAN TONY T SVP, Chief Accounting Officer | Grant or award · Option to purchase common stock | +204,000 | 204,000 | ||
| 2020-02-10 | Parker Albert P Chief Operating Officer | Grant or award · Option to purchase common stock | +204,000 | 204,000 | ||
| 2020-02-10 | Sundar Padma SVP, Marketing & Market Access | Grant or award · Option to purchase common stock | +255,000 | 255,000 | ||
| 2020-01-02 | Lineage Cell Therapeutics, Inc. Previous 10% Owner | Sale | −2,383,090 | $2.16 | $5.1M | 6,041,154 |
| 2020-01-02 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +768,376 | $2.16 | $1.7M | 13,043,114 |
| 2020-01-02 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 13,043,114 | ||
| 2020-01-02 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +623,090 | $2.16 | $1.3M | 13,666,204 |
| 2020-01-02 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 13,666,204 | ||
| 2019-11-13 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +1,176,471 | $1.70 | $2.0M | 12,274,738 |
| 2019-11-13 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 12,274,738 | ||
| 2019-09-17 | Arno Andrew Director | Purchase | +50,000 | $2.16 | $108K | 102,447 |
| 2019-09-13 | KALAJIAN TONY T SVP-Chief Accounting Officer | Purchase | +10,000 | $1.98 | $20K | 10,000 |
| 2019-09-12 | Levine Mitchell S CFO | Purchase | +10,000 | $2.01 | $20K | 13,495 |
| 2019-09-12 | Levine Mitchell S Chief Financial Officer | Purchase | +10,000 | $2.01 | $20K | 10,000 |
| 2019-09-11 | Lineage Cell Therapeutics, Inc. 10% owner | Sale | −4,000,000 | $1.66 | $6.6M | 8,424,244 |
| 2019-09-11 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +2,000,000 | $1.66 | $3.3M | 11,098,267 |
Page 17 of 20 · 383 trades